1.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673
2.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661
3.
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
by Fufaa, Gudeta D
Diabetologia, 2014-10-15, Vol.58 (1), p.188-198
4.
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis...
by Bakris, George L, Dr, Prof
The Lancet (British edition), 2010, Vol.375 (9721), p.1173-1181
5.
Association of Initial Twice-Weekly Hemodialysis Treatment with Preservation of Residual Kidney Function in ESRD Patients
by Zhang, Minmin
American journal of nephrology, 2014-09, Vol.40 (2), p.140-150
6.
Oxidative Balance Score and Chronic Kidney Disease
by Ilori, Titilayo O
American journal of nephrology, 2015-11, Vol.42 (4), p.320-327
7.
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
by Lambert, Nathan D., MD
The American heart journal, 2009, Vol.157 (4), p.688-694
8.
Kidney Function and Systolic Blood Pressure New Insights From Cystatin C: Data from the Heart and Soul Study
by Peralta, Carmen A
American journal of hypertension, 2006, Vol.19 (9), p.939-946
9.
Chronic renal failure-induced changes in serum and urine bile acid profiles
by Jimenez, F
Digestive diseases and sciences, 2002-11, Vol.47 (11), p.2398-2406
10.
Effect of Erythropoietin on Urinary Liver-Type Fatty-Acid-Binding Protein in Patients with Chronic Renal Failure and Anemia
by Nakamura, Tsukasa
American journal of nephrology, 2006-07, Vol.26 (3), p.276-280
11.
Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man
by SNOECK, E
Psychopharmacologia, 1995, Vol.122 (3), p.223-229
12.
Effect of enalapril on the progression of chronic renal failure : a randomized controlled trial
by KAMPER, A.-L
American journal of hypertension, 1992, Vol.5 (7), p.423-430
13.
Urinary Deoxypyridinoline Excretion for the Evaluation of Bone Turnover in Chronic Renal Failure
by Coen, Giorgio
American journal of nephrology, 2000-08, Vol.20 (4), p.283-290
14.
An evaluation of the influence of therapeutic interventions on serum trace element levels in groups of patients
by Senft, Václav
Journal of trace elements in medicine and biology, 2003, Vol.17 (1), p.7-11
15.
Urinary growth hormone levels measured by ultrasensitive enzyme immunoassay in patients with renal insufficiency
by HATTORI, N
The journal of clinical endocrinology and metabolism, 1988, Vol.66 (4), p.727-732
16.
The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate
by KNAUF, H
European journal of clinical pharmacology, 1994, Vol.46 (1), p.9-13
17.
Role of Urinary Arginine Vasopressin in the Sodium Excretion in Patients With Chronic Renal Failure
by Nonoguchi, Hiroshi
The American journal of the medical sciences, 1996-11, Vol.312 (5), p.195-201
18.
Constant K+/Na+ excretion ratio during peak diuresis after piretanide but insignificant K+ loss during 24 hours
by KNAUF, H
European journal of clinical pharmacology, 1992, Vol.43 (1), p.23-27
19.
Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion
by Knauf, H
European journal of clinical pharmacology, 1990, Vol.39 (4), p.337-343
20.
Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man
by LIN, J. H
European journal of clinical pharmacology, 1988, Vol.34 (1), p.41-46
